东莨菪碱市场：按类型、管理方法分类 - 全球预测 2025-2030

2023年东莨菪碱市值为4.3916亿美元，预计到2024年将达到4.6041亿美元，复合年增长率为4.66%，预计到2030年将达到6.0428亿美元。

东莨菪碱，也称为东莨菪碱，是一种生物碱药物，主要用于治疗晕动病和术后噁心和呕吐。作为抗胆碱能药物，阻断中枢和周围神经系统中的神经传导物质乙酰胆碱。对东莨菪碱的需求源于其预防噁心的作用，其应用范围扩展到大肠激躁症和肌肉痉挛等其他疾病的治疗，这说明了其在製药业的多方面应用。最常见的是经皮吸收贴片、口服锭剂和静脉注射剂，它们广泛用于临床环境、非处方药和急诊医学。东莨菪碱市场受到旅行活动增加导致晕车盛行率增加、胃肠道治疗应用扩大以及神经退化性疾病治疗持续研究等因素的显着影响。还有机会扩大在动物用药品的应用并开发新的给药方法以提高疗效并减少副作用。为了抓住这些机会，建议投资先进的研发以及与旅游产业相关人员的合作，从而提高产品的知名度和接受度。然而，法律规范、抗胆碱能药物通用的副作用（如口干、嗜睡和视力模糊）以及来自替代疗法的竞争等因素正在阻碍成长。技术创新的重点可能是开发更具选择性的东莨菪碱衍生物，减少副作用，并探索在阿兹海默症认知障碍中的潜在应用。儘管市场竞争激烈，但在新兴国家不断扩大的治疗应用和不断增长的需求的推动下，这是一个充满前景的市场。公司需要根据消费者需求和监管环境调整策略，以最大限度地发挥市场潜力。

市场动态：揭示快速发展的东莨菪碱市场的关键市场洞察

供应和需求的动态交互作用正在改变东莨菪市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

• 市场驱动因素
  • 人们越来越认识到使用东莨菪碱作为晕动病药物
  • 旅客数量和国际观光的增加
  • 东莨菪碱作为非处方药的可用性
• 市场限制因素
  • 高成本和严格的监管通讯协定
• 市场机会
  • 在手术和术后恢復中增加经皮莨菪贴剂的使用
  • 改良东莨菪生产工艺
• 市场问题
  • 与东莨菪碱相关的副作用

波特的五力：驾驭东莨菪市场的策略工具

波特的五力架构是了解东莨菪市场竞争格局的关键工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解东莨菪市场的外部影响

外部宏观环境因素在塑造东莨菪市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解东莨菪碱市场的竞争状况

对东莨菪市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵：东莨菪市场供应商绩效评估

FPNV定位矩阵是评估东紫星市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製东莨菪市场的成功之路

对于想要加强在全球市场的影响力的公司来说，对东莨菪碱市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争格局中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

• 市场动态
  • 促进因素
    • 人们对使用东莨菪碱作为晕车药的认识有所提高
    • 旅客数量和国际观光的增加
    • 东莨菪碱可以当非处方药吗？
  • 抑制因素
    • 高成本和严格的监管通讯协定
  • 机会
    • 在手术期间和术后恢復期间增加经皮吸收贴片的使用
    • 改良东莨菪碱生产工艺
  • 任务
    • 与东莨菪碱相关的副作用
• 市场区隔分析
• 波特五力分析
• PESTEL分析
  • 政治
  • 经济
  • 社会
  • 科技
  • 法律
  • 环境

第六章东莨菪碱市场：依类型

• 介绍
• 丁溴东莨菪碱
• 氢溴东莨菪碱

第七章 东莨菪碱市场：依管理方式分类

• 介绍
• 注射
• 口服
• 修补

第八章美洲东莨菪市场

• 介绍
• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第九章 亚太东莨菪碱市场

• 介绍
• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第十章 欧洲、中东、非洲东莨菪市场

• 介绍
• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第十一章竞争格局

• 2023 年市场占有率分析
• FPNV 定位矩阵，2023
• 竞争情境分析
• 战略分析和建议

公司名单

• Alchem International Pvt. Ltd.
• Alkaloids Corporation
• Baxter International, Inc.
• C-Squared Pharma Sa RL
• Caleb Pharmaceuticals, Inc
• GlaxoSmithKline PLC
• Linnea SA
• Merck KGaA
• Morningside Healthcare Limited by Aspire Pharma Limited
• Myungmoon Pharm Co., Ltd.
• Perrigo Company PLC
• Pfizer Inc.
• Sanofi SA
• Teva Pharmaceuticals Industries Ltd.
• Wockhardt UK Limited

The Hyoscine Market was valued at USD 439.16 million in 2023, expected to reach USD 460.41 million in 2024, and is projected to grow at a CAGR of 4.66%, to USD 604.28 million by 2030.

Hyoscine, also known as scopolamine, is an alkaloid medication primarily used to treat motion sickness and postoperative nausea and vomiting. It is found in certain plants of the nightshade family and operates as an anticholinergic agent, blocking the neurotransmitter acetylcholine in the central and the peripheral nervous system. The necessity of hyoscine arises from its effectiveness in preventing nausea and its application extends to treatment of other conditions such as irritable bowel syndrome and muscle spasms, providing a multifaceted scope for the pharmaceutical industry. It is most commonly utilized in transdermal patch form, oral tablets, and intravenous injections, allowing widespread end-use in clinical settings, over-the-counter products, and emergency care. The market for hyoscine is significantly influenced by factors such as an increasing prevalence of motion sickness due to rising travel activities, expanding applications in gastrointestinal treatments, and ongoing research into neurodegenerative disease therapies. Opportunities lie in expanding the use in veterinary medicine, and formulating new delivery methods that enhance efficacy or reduce side effects. To capture these opportunities, investing in advanced R&D and collaboration with travel industry stakeholders is recommended, thereby enhancing product visibility and acceptance. However, growth is hindered by factors like stringent regulatory frameworks, potential side effects common to anticholinergics, including dry mouth, drowsiness, and blurred vision, and the competition from alternative therapies. Innovations may focus on developing hyoscine derivatives with higher selectivity, reducing adverse effects, and exploring potential use in cognitive disorders, such as Alzheimer's disease. The market is competitive yet promising, driven by expanding therapeutic applications and growing demand in emerging economies. Businesses must align their strategies to emerging consumer needs and regulatory landscapes to harness the full market potential of hyoscine.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hyoscine Market

The Hyoscine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing awareness about the use of hyoscine as an apt medicine against motion sickness
  • Growing number of travelers and international tourism
  • Availability of hyoscine as over-the-counter medicine
• Market Restraints
  • High cost and stringent regulatory protocols
• Market Opportunities
  • Increase in usage of transdermal hyoscine patches in surgeries & post-operative recovery
  • Improvements in production process of hyoscine
• Market Challenges
  • Side effects associated with hyoscine

Porter's Five Forces: A Strategic Tool for Navigating the Hyoscine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hyoscine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Hyoscine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hyoscine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Hyoscine Market

A detailed market share analysis in the Hyoscine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hyoscine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hyoscine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Hyoscine Market

A strategic analysis of the Hyoscine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hyoscine Market, highlighting leading vendors and their innovative profiles. These include Alchem International Pvt. Ltd., Alkaloids Corporation, Baxter International, Inc., C-Squared Pharma S.a R.L., Caleb Pharmaceuticals, Inc, GlaxoSmithKline PLC, Linnea SA, Merck KGaA, Morningside Healthcare Limited by Aspire Pharma Limited, Myungmoon Pharm Co., Ltd., Perrigo Company PLC, Pfizer Inc., Sanofi S.A., Teva Pharmaceuticals Industries Ltd., and Wockhardt UK Limited.

Market Segmentation & Coverage

This research report categorizes the Hyoscine Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Hyoscine Butylbromide and Hyoscine Hydrobromide.
• Based on Mode of Administration, market is studied across Injections, Oral, and Patches.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing awareness about the use of hyoscine as an apt medicine against motion sickness
    • 5.1.1.2. Growing number of travelers and international tourism
    • 5.1.1.3. Availability of hyoscine as over-the-counter medicine
  • 5.1.2. Restraints
    • 5.1.2.1. High cost and stringent regulatory protocols
  • 5.1.3. Opportunities
    • 5.1.3.1. Increase in usage of transdermal hyoscine patches in surgeries & post-operative recovery
    • 5.1.3.2. Improvements in production process of hyoscine
  • 5.1.4. Challenges
    • 5.1.4.1. Side effects associated with hyoscine
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Hyoscine Market, by Type

• 6.1. Introduction
• 6.2. Hyoscine Butylbromide
• 6.3. Hyoscine Hydrobromide

7. Hyoscine Market, by Mode of Administration

• 7.1. Introduction
• 7.2. Injections
• 7.3. Oral
• 7.4. Patches

8. Americas Hyoscine Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Hyoscine Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Hyoscine Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Alchem International Pvt. Ltd.
• 2. Alkaloids Corporation
• 3. Baxter International, Inc.
• 4. C-Squared Pharma S.a R.L.
• 5. Caleb Pharmaceuticals, Inc
• 6. GlaxoSmithKline PLC
• 7. Linnea SA
• 8. Merck KGaA
• 9. Morningside Healthcare Limited by Aspire Pharma Limited
• 10. Myungmoon Pharm Co., Ltd.
• 11. Perrigo Company PLC
• 12. Pfizer Inc.
• 13. Sanofi S.A.
• 14. Teva Pharmaceuticals Industries Ltd.
• 15. Wockhardt UK Limited

LIST OF FIGURES

• FIGURE 1. HYOSCINE MARKET RESEARCH PROCESS
• FIGURE 2. HYOSCINE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HYOSCINE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HYOSCINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL HYOSCINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL HYOSCINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES HYOSCINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES HYOSCINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. HYOSCINE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. HYOSCINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HYOSCINE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HYOSCINE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HYOSCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HYOSCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HYOSCINE MARKET DYNAMICS
• TABLE 7. GLOBAL HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HYOSCINE MARKET SIZE, BY HYOSCINE BUTYLBROMIDE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HYOSCINE MARKET SIZE, BY HYOSCINE HYDROBROMIDE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HYOSCINE MARKET SIZE, BY INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HYOSCINE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HYOSCINE MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS HYOSCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 21. CANADA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 22. CANADA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES HYOSCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 33. CHINA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. CHINA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 35. INDIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. INDIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 70. ITALY HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. ITALY HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 78. POLAND HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. POLAND HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 80. QATAR HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. QATAR HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 100. HYOSCINE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 101. HYOSCINE MARKET, FPNV POSITIONING MATRIX, 2023